Global Neprilysin Market Research Report 2023

Report ID: 1978390 | Published Date: Jan 2025 | No. of Page: 70 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Neprilysin Market Overview
    1.1 Product Overview and Scope of Neprilysin
    1.2 Neprilysin Segment by Type
        1.2.1 Global Neprilysin Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 TD-0714
        1.2.3 STR-324
        1.2.4 PL-265
        1.2.5 LHW-090
        1.2.6 Others
    1.3 Neprilysin Segment by Application
        1.3.1 Global Neprilysin Sales Comparison by Application: (2022-2028)
        1.3.2 Acute Heart Failure
        1.3.3 Cancer Pain
        1.3.4 Hypertension
        1.3.5 Alzheimer's Disease
        1.3.6 Others
    1.4 Global Neprilysin Market Size Estimates and Forecasts
        1.4.1 Global Neprilysin Revenue 2017-2028
        1.4.2 Global Neprilysin Sales 2017-2028
        1.4.3 Neprilysin Market Size by Region: 2017 Versus 2021 Versus 2028
2 Neprilysin Market Competition by Manufacturers
    2.1 Global Neprilysin Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Neprilysin Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Neprilysin Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Neprilysin Manufacturing Sites, Area Served, Product Type
    2.5 Neprilysin Market Competitive Situation and Trends
        2.5.1 Neprilysin Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Neprilysin Players Market Share by Revenue
        2.5.3 Global Neprilysin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neprilysin Retrospective Market Scenario by Region
    3.1 Global Neprilysin Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Neprilysin Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Neprilysin Market Facts & Figures by Country
        3.3.1 North America Neprilysin Sales by Country
        3.3.2 North America Neprilysin Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Neprilysin Market Facts & Figures by Country
        3.4.1 Europe Neprilysin Sales by Country
        3.4.2 Europe Neprilysin Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Neprilysin Market Facts & Figures by Region
        3.5.1 Asia Pacific Neprilysin Sales by Region
        3.5.2 Asia Pacific Neprilysin Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Neprilysin Market Facts & Figures by Country
        3.6.1 Latin America Neprilysin Sales by Country
        3.6.2 Latin America Neprilysin Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Neprilysin Market Facts & Figures by Country
        3.7.1 Middle East and Africa Neprilysin Sales by Country
        3.7.2 Middle East and Africa Neprilysin Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Neprilysin Historic Market Analysis by Type
    4.1 Global Neprilysin Sales Market Share by Type (2017-2022)
    4.2 Global Neprilysin Revenue Market Share by Type (2017-2022)
    4.3 Global Neprilysin Price by Type (2017-2022)
5 Global Neprilysin Historic Market Analysis by Application
    5.1 Global Neprilysin Sales Market Share by Application (2017-2022)
    5.2 Global Neprilysin Revenue Market Share by Application (2017-2022)
    5.3 Global Neprilysin Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Bioprojet SCR
        6.1.1 Bioprojet SCR Corporation Information
        6.1.2 Bioprojet SCR Description and Business Overview
        6.1.3 Bioprojet SCR Neprilysin Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Bioprojet SCR Neprilysin Product Portfolio
        6.1.5 Bioprojet SCR Recent Developments/Updates
    6.2 Novartis AG
        6.2.1 Novartis AG Corporation Information
        6.2.2 Novartis AG Description and Business Overview
        6.2.3 Novartis AG Neprilysin Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Novartis AG Neprilysin Product Portfolio
        6.2.5 Novartis AG Recent Developments/Updates
    6.3 Pharmaleads SA
        6.3.1 Pharmaleads SA Corporation Information
        6.3.2 Pharmaleads SA Description and Business Overview
        6.3.3 Pharmaleads SA Neprilysin Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Pharmaleads SA Neprilysin Product Portfolio
        6.3.5 Pharmaleads SA Recent Developments/Updates
    6.4 Theravance Biopharma Inc
        6.4.1 Theravance Biopharma Inc Corporation Information
        6.4.2 Theravance Biopharma Inc Description and Business Overview
        6.4.3 Theravance Biopharma Inc Neprilysin Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Theravance Biopharma Inc Neprilysin Product Portfolio
        6.4.5 Theravance Biopharma Inc Recent Developments/Updates
7 Neprilysin Manufacturing Cost Analysis
    7.1 Neprilysin Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Neprilysin
    7.4 Neprilysin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Neprilysin Distributors List
    8.3 Neprilysin Customers
9 Neprilysin Market Dynamics
    9.1 Neprilysin Industry Trends
    9.2 Neprilysin Market Drivers
    9.3 Neprilysin Market Challenges
    9.4 Neprilysin Market Restraints
10 Global Market Forecast
    10.1 Neprilysin Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Neprilysin by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Neprilysin by Type (2023-2028)
    10.2 Neprilysin Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Neprilysin by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Neprilysin by Application (2023-2028)
    10.3 Neprilysin Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Neprilysin by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Neprilysin by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Neprilysin Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Neprilysin Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Neprilysin Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Neprilysin Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Neprilysin Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Neprilysin Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Neprilysin Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Neprilysin Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Neprilysin Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Neprilysin Manufacturing Sites and Area Served
    Table 11. Manufacturers Neprilysin Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Neprilysin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neprilysin as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Neprilysin Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Neprilysin Sales Market Share by Region (2017-2022)
    Table 17. Global Neprilysin Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Neprilysin Revenue Market Share by Region (2017-2022)
    Table 19. North America Neprilysin Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Neprilysin Sales Market Share by Country (2017-2022)
    Table 21. North America Neprilysin Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Neprilysin Revenue Market Share by Country (2017-2022)
    Table 23. Europe Neprilysin Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Neprilysin Sales Market Share by Country (2017-2022)
    Table 25. Europe Neprilysin Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Neprilysin Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Neprilysin Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Neprilysin Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Neprilysin Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Neprilysin Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Neprilysin Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Neprilysin Sales Market Share by Country (2017-2022)
    Table 33. Latin America Neprilysin Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Neprilysin Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Neprilysin Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Neprilysin Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Neprilysin Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Neprilysin Revenue Market Share by Country (2017-2022)
    Table 39. Global Neprilysin Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Neprilysin Sales Market Share by Type (2017-2022)
    Table 41. Global Neprilysin Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Neprilysin Revenue Share by Type (2017-2022)
    Table 43. Global Neprilysin Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Neprilysin Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Neprilysin Sales Market Share by Application (2017-2022)
    Table 46. Global Neprilysin Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Neprilysin Revenue Share by Application (2017-2022)
    Table 48. Global Neprilysin Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Bioprojet SCR Corporation Information
    Table 50. Bioprojet SCR Description and Business Overview
    Table 51. Bioprojet SCR Neprilysin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Bioprojet SCR Neprilysin Product
    Table 53. Bioprojet SCR Recent Developments/Updates
    Table 54. Novartis AG Corporation Information
    Table 55. Novartis AG Description and Business Overview
    Table 56. Novartis AG Neprilysin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Novartis AG Neprilysin Product
    Table 58. Novartis AG Recent Developments/Updates
    Table 59. Pharmaleads SA Corporation Information
    Table 60. Pharmaleads SA Description and Business Overview
    Table 61. Pharmaleads SA Neprilysin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Pharmaleads SA Neprilysin Product
    Table 63. Pharmaleads SA Recent Developments/Updates
    Table 64. Theravance Biopharma Inc Corporation Information
    Table 65. Theravance Biopharma Inc Description and Business Overview
    Table 66. Theravance Biopharma Inc Neprilysin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Theravance Biopharma Inc Neprilysin Product
    Table 68. Theravance Biopharma Inc Recent Developments/Updates
    Table 69. Production Base and Market Concentration Rate of Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Neprilysin Distributors List
    Table 72. Neprilysin Customers List
    Table 73. Neprilysin Market Trends
    Table 74. Neprilysin Market Drivers
    Table 75. Neprilysin Market Challenges
    Table 76. Neprilysin Market Restraints
    Table 77. Global Neprilysin Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 78. Global Neprilysin Sales Market Share Forecast by Type (2023-2028)
    Table 79. Global Neprilysin Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 80. Global Neprilysin Revenue Market Share Forecast by Type (2023-2028)
    Table 81. Global Neprilysin Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 82. Global Neprilysin Sales Market Share Forecast by Application (2023-2028)
    Table 83. Global Neprilysin Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 84. Global Neprilysin Revenue Market Share Forecast by Application (2023-2028)
    Table 85. Global Neprilysin Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 86. Global Neprilysin Sales Market Share Forecast by Region (2023-2028)
    Table 87. Global Neprilysin Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 88. Global Neprilysin Revenue Market Share Forecast by Region (2023-2028)
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Neprilysin
    Figure 2. Global Neprilysin Market Share by Type in 2021 & 2028
    Figure 3. TD-0714 Product Picture
    Figure 4. STR-324 Product Picture
    Figure 5. PL-265 Product Picture
    Figure 6. LHW-090 Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Neprilysin Market Share by Application in 2021 & 2028
    Figure 9. Acute Heart Failure
    Figure 10. Cancer Pain
    Figure 11. Hypertension
    Figure 12. Alzheimer's Disease
    Figure 13. Others
    Figure 14. Global Neprilysin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Neprilysin Market Size (2017-2028) & (US$ Million)
    Figure 16. Global Neprilysin Sales (2017-2028) & (K Pcs)
    Figure 17. Neprilysin Sales Share by Manufacturers in 2021
    Figure 18. Global Neprilysin Revenue Share by Manufacturers in 2021
    Figure 19. The Global 5 and 10 Largest Neprilysin Players: Market Share by Revenue in 2021
    Figure 20. Neprilysin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 21. Global Neprilysin Sales Market Share by Region (2017-2022)
    Figure 22. Global Neprilysin Sales Market Share by Region in 2021
    Figure 23. Global Neprilysin Revenue Market Share by Region (2017-2022)
    Figure 24. Global Neprilysin Revenue Market Share by Region in 2021
    Figure 25. U.S. Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Canada Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Germany Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. France Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. U.K. Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Italy Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Russia Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Japan Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. South Korea Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. India Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Australia Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Taiwan Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Indonesia Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Thailand Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Malaysia Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Philippines Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Vietnam Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Mexico Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Brazil Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Argentina Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Turkey Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Saudi Arabia Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. UAE Neprilysin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. Sales Market Share of Neprilysin by Type (2017-2022)
    Figure 50. Manufacturing Cost Structure of Neprilysin
    Figure 51. Manufacturing Process Analysis of Neprilysin
    Figure 52. Neprilysin Industrial Chain Analysis
    Figure 53. Channels of Distribution
    Figure 54. Distributors Profiles
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
Frequently Asked Questions
Neprilysin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neprilysin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neprilysin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

20s Proteasome

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Catenin Beta 1

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More